RuCl(p-cymene)[(R,R)-Ts-DPEN]

• Catalog No.: 703907
• CAS Number: 192139-92-7
• M. F.: C31H35ClN2O2RuS
• M. W.: 636.2098

SYNONYMS

• Title: RuCl(p-异丙基甲苯)[(R,R)-Ts-DPEN]
• IUPAC name: 1-methyl-4-(propan-2-yl)benzene; N-[(1R,2R)-2-amino-1,2-diphenylethyl]-N-(chlororuthenio)-4-methylbenzene-1-sulfonamide
• IUPAC Traditional name: N-[(1R,2R)-2-amino-1,2-diphenylethyl]-N-(chlororuthenio)-4-methylbenzenesulfonamide; cymene
• Synonyms: [N-[(1R,2R)-2-(氨基-κN)-1,2-二苯基乙基]-4-甲基苯磺酰胺合-κN]氯[(1,2,3,4,5,6-η)-1-甲基-4-(1-甲基乙基)苯]-钌; [N-[(1R,2R)-2-(Amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-κN]chloro[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]-ruthenium

DATABASE IDS

• MDL Number: MFCD10567385
• CAS Number: 192139-92-7

PROPERTIES

• Empirical Formula (Hill Notation): C31H35ClN2O2RuS
• Melting Point: 215 °C
• Optical Rotation: [α]20/D -116°, c = 0.1 in chloroform
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• Storage Temperature: 2-8°C
• German water hazard class: 3

DETAILS

Description (English)

Packaging
100, 500 mg in glass bottle
Legal Information
Sold in collaboration with Takasago for research purposes only. WO9720789
Application
Takasago Ligands and Complexes for Asymmetric Reactions
Phosphine cationic ruthenium catalysts used for enantioselective hydrogenation of:
• Quinolines
• N-Alkyl ketimines
• Antitumor and antiproliferative derivatives of natural products isolated from bacteria
• Hydroxy arylaldehydes via Rap-Stoermer-enantioselective transfer hydrogenationCatalyst with improved performance modified via microenvironment engineering of nanocages

Description (简体中文)

包装
100, 500 mg in glass bottle
Legal Information
与 Takasago 合作销售，仅用于研究目的。WO9720789
Application
Takasago Ligands and Complexes for Asymmetric Reactions
Phosphine cationic ruthenium catalysts used for enantioselective hydrogenation of:
• Quinolines
• N-Alkyl ketimines
• Antitumor and antiproliferative derivatives of natural products isolated from bacteria
• Hydroxy arylaldehydes via Rap-Stoermer-enantioselective transfer hydrogenationCatalyst with improved performance modified via microenvironment engineering of nanocages